Finance

Lists
Why is BLTE down 4.03%?
Dive Deeper
BLTE:NASDAQ
Belite Bio Inc
$ 162.98
-4.03%
(-6.84) 1D
$ 162.98
0.00% (0.00)
After hours
Closed: 10-р сарын 1, 16:00:01 (GMT-4)  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BLTE...
Open
$ 168.98
High
$ 170.36
Low
$ 162.98
Mkt. cap
6.56 тэрбум
Avg. vol.
189.70 мян
Volume
198.81 мян
52-wk high
$ 200.00
52-wk low
$ 70.80
EPS
-$ 2.85
Beta
-1.23
Shares outstanding
40.27 сая
No. of employees
41
Open
$ 168.98
High
$ 170.36
Low
$ 162.98
Mkt. cap
6.56 тэрбум
Avg. vol.
189.70 мян
Volume
198.81 мян
52-wk high
$ 200.00
52-wk low
$ 70.80
EPS
-$ 2.85
Beta
-1.23
Shares outstanding
40.27 сая
No. of employees
41
News stories
From web sources and news partners
About Belite Bio Inc
CEO-
Employees41
Founded2016
Headquarters-
SectorPharmaceutical industry
Analyst ratings
Based on 7 analysts giving stock ratings to BLTE in the past 3 months
Strong buy
Buy
7
Hold
0
Sell
0
12-month forecast
Based on 7 Wall Street analysts offering 12 month price targets for BLTE in the last 3 months.
Highest
Current $ 162.98
$ 303.00 (+85.91%)
Average
$ 236.86 (+45.33%)
Lowest
$ 200.00 (+22.71%)
Analyst
Recommendation
Action
Price target
Projected
Date
Graig Suvannavejh
Mizuho Securities
Buy
Maintained
$ 234.00
+43.6%
09/09/2026
Yi Chen
H.C. Wainwright
Buy
Reiterated
$ 245.00
+50.3%
09/09/2026
Whitney Ijem
Canaccord Genuity
Buy
Initiated
$ 303.00
+85.9%
09/04/2026
Tazeen Ahmad
Bank of America Securities
Buy
Maintained
$ 200.00
+22.7%
09/02/2026
Judah Frommer
Morgan Stanley
Buy
Maintained
$ 206.00
+26.4%
08/17/2026
Michael Okunewitch
Maxim Group
Buy
Maintained
$ 200.00
+22.7%
08/14/2026
Steven Seedhouse
Cantor Fitzgerald
Buy
Maintained
$ 270.00
+65.7%
08/14/2026
Bruce Jackson
Benchmark Co.
Buy
Maintained
$ 217.00
+33.1%
03/03/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 оны 9-р сар
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
10.31 сая
14.62 сая
15.66 сая
18.21 сая
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
12.71 сая
13.45 сая
17.02 сая
16.69 сая
Operating expense
23.02 сая
28.08 сая
32.68 сая
34.91 сая
Total operating expenses
23.02 сая
28.08 сая
32.68 сая
34.91 сая
Operating income
-23.02 сая
-28.08 сая
-32.68 сая
-34.91 сая
Other non operating income
-2.14 сая
-417.00 мян
5.75 сая
6.55 сая
EBT including unusual items
-21.69 сая
-25.32 сая
-26.94 сая
-28.36 сая
EBT excluding unusual items
-21.69 сая
-25.32 сая
-26.94 сая
-28.36 сая
Income tax expense
-
-
-
55.00 мян
Effective tax rate
-
-
-
-0.19%
Other operating expenses
-
-
-
-
Net income
-21.69 сая
-25.32 сая
-26.94 сая
-28.41 сая
Net profit margin
-
-
-
-
Earnings per share
-0.65
-0.70
-0.68
-0.70
Interest and investment income
3.47 сая
3.17 сая
-
-
Interest expense
-
-2.00 мян
-
-
Net interest expenses
3.47 сая
3.17 сая
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-22.97 сая
-28.03 сая
-32.64 сая
-34.86 сая
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google аппс